156 related articles for article (PubMed ID: 15497903)
1. Use and perception of hormone therapy following media reports of the Women's Health Initiative: a survey of Australian WISDOM participants.
Paine BJ; Stocks NP; Ramsay EN; Ryan P; MacLennan AH;
Climacteric; 2004 Jun; 7(2):143-52. PubMed ID: 15497903
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy use after the Women's Health Initiative.
MacLennan AH; Taylor AW; Wilson DH
Climacteric; 2004 Jun; 7(2):138-42. PubMed ID: 15497902
[TBL] [Abstract][Full Text] [Related]
3. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
[TBL] [Abstract][Full Text] [Related]
4. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
6. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
7. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
[TBL] [Abstract][Full Text] [Related]
8. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
9. The 2017 Women's Health Initiative study and use of hormone therapy: an emulated repeated cross-sectional study.
Chueh CH; Ho PK; Li WH; Shiu MN; Wang IT; Wen YW; Tsai YW
BMC Public Health; 2024 Jun; 24(1):1674. PubMed ID: 38914983
[TBL] [Abstract][Full Text] [Related]
10. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
11. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
Gerend MA; Aiken LS; Erchull MJ; Lapin A
Prev Med; 2006 Sep; 43(3):158-64. PubMed ID: 16750263
[TBL] [Abstract][Full Text] [Related]
12. Patients' and clinicians' attitudes after the Women's Health Initiative study.
Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
[TBL] [Abstract][Full Text] [Related]
13. The hormone therapy dilemma: women respond.
Breslau ES; Davis WW; Doner L; Eisner EJ; Goodman NR; Meissner HI; Rimer BK; Rossouw JE
J Am Med Womens Assoc (1972); 2003; 58(1):33-43. PubMed ID: 12553641
[TBL] [Abstract][Full Text] [Related]
14. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
15. Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre.
Natari RB; Hollingworth SA; Clavarino AM; Dingle KD; McGuire TM
BMC Womens Health; 2021 Oct; 21(1):348. PubMed ID: 34607596
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.
Ettinger B; Grady D; Tosteson AN; Pressman A; Macer JL
Obstet Gynecol; 2003 Dec; 102(6):1225-32. PubMed ID: 14662208
[TBL] [Abstract][Full Text] [Related]
18. Changing use of hormone therapy among minority women since the Women's Health Initiative.
Helenius IM; Korenstein D; Halm EA
Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey.
Sawka AM; Huh A; Dolovich L; Papaioannou A; Eva K; Thabane L; Gafni A; Cullimore A; Macdougall M; Steiner M; Adachi JD
J Obstet Gynaecol Can; 2004 Nov; 26(11):967-73. PubMed ID: 15560859
[TBL] [Abstract][Full Text] [Related]
20. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]